These results suggest that irisin might be a useful agent in the treatment of abnormal vasoconstriction-related diseases such as hypertension and atherosclerosis, in addition to its key role in regulating energy metabolism, resulting in thermogenesis and weight loss, by increasing uncoupling protein-1 (UCP-1) expression in adipose tissue. The gene discussed is FNDC5; the disease is atherosclerosis.